No, this is not an approval, but it is an emergency use authorization to use the antiviral Remdesivir for COVID 19 patients.  The FDA issued this EUA on Friday, in record time, after positive results of the study involving Gilead’s drug.  The EUA will remain in effect until the COVID 19 public health emergency is over or the drug receives full FDA approval.  This will make the drug available for critically ill patients immediately.

FDA issues a fact sheet for patients upon issuance of the EUA.  A Copy of which can be viewed here.  To learn more about EUAs click here.